How to Tell If a Health Claim Is Backed by Science

Health claims reach you from headlines, social feeds, product labels, and friends, and many of them cite "a study." Some of those studies are strong. Many are early, small, or narrower than the claim built on them. Knowing the difference saves money and disappointment, and it helps you notice when something genuinely promising comes along.

This guide explains the main types of evidence, gives you six questions to ask of any claim, shows where claims tend to get distorted, and is honest about what these questions cannot settle. It also sets out the evidence vocabulary every article on HEXABIOME Learn uses.

Not all evidence carries the same weight

The type of study tells you more about a claim than its confident wording does. Researchers often picture evidence as a pyramid. Systematic reviews and meta-analyses are usually placed at the top, although some methodologists argue they are better seen as tools for appraising and applying the studies beneath them [1]. The table below summarizes the main study types in the order they are usually ranked.

A review is not automatically trustworthy. Reporting guidelines such as PRISMA 2020 set out what a systematic review should disclose so readers can check it: why it was done, what the authors did, and what they found [2]. A review that does not explain how it searched for and selected studies is harder to rely on.

For a fuller walk through each level, see Evidence Levels: From a Single Study to a Systematic Review.

Six questions to ask of any health claim

These six questions catch most weak claims, and none of them requires a science degree.

1. What kind of study is it?

Start by finding the study type, using the table above. A claim built on one observational study or one lab experiment is a starting point, not a conclusion. If a claim does not say what kind of study supports it, that is useful information in itself.

2. Who, or what, was studied?

Results in cells or animals are early signals. A 2024 umbrella review of 122 systematic reviews, covering 367 therapies first tested in animals, found that about 50% went on to any human study, 40% to a randomized trial, and 5% to regulatory approval [3]. The same analysis found 86% agreement between positive animal and human results, so animal research is informative [3]. Even so, a positive animal result is an early step, not an answer for people. When the study was in humans, check whether those people resemble you in age, sex, and health status.

3. What was actually measured?

Many studies measure a biomarker rather than something you would notice. The FDA and NIH define a biomarker as a characteristic measured as an indicator of normal biological processes, disease processes, or responses to an exposure or intervention, and note: "A biomarker is not an assessment of how an individual feels, functions, or survives" [4]. A change in a blood marker, a gut bacteria count, or a brain scan can be a real finding without meaning you will feel or function differently. Look for outcomes that matter to you, and notice whether they were measured objectively or reported by participants.

4. Does it show cause, or only a link?

An association means two things tend to occur together. It does not show that one causes the other. A well-known example comes from beta carotene. Observational studies had linked diets high in carotenoid-rich fruits and vegetables, and higher blood levels of beta carotene, with lower lung cancer risk [5]. A randomized, placebo-controlled trial then gave 29,133 male smokers aged 50 to 69 in Finland 20 mg of beta carotene a day, 50 mg of vitamin E a day, both, or placebo, for five to eight years. The investigators reported: "Unexpectedly, we observed a higher incidence of lung cancer among the men who received beta carotene than among those who did not" [5].

This example does not show that beta carotene from food is harmful, and the trial studied only male smokers. What it shows is that a consistent association was not a reliable guide to what a supplement would do when it was tested directly.

5. How large is the evidence, and has it been repeated?

Small studies tend to report larger effects than big ones. In an analysis of 735 randomized trials across 93 meta-analyses, treatment effects in trials with fewer than 50 patients were, on average, 48% larger than in trials with 1,000 patients or more [6]. Early findings can also fade. Of 45 highly cited clinical studies that reported an intervention was effective, 7 were later contradicted, 7 had found stronger effects than later studies, 20 were replicated, and 11 remained largely unchallenged [7]. Five of the 6 nonrandomized studies in that group had been contradicted or had found stronger effects, compared with 9 of 39 randomized trials [7]. One study, especially a small or nonrandomized one, rarely settles a question.

6. Who paid for it, and do the conclusions match the results?

Funding does not make a study wrong, but it is worth checking. A Cochrane review of 75 papers on drug and device research found that industry-sponsored studies more often reported favorable efficacy results and favorable conclusions than studies with other sponsors [8]. That review covered drugs and devices, not supplements specifically. Separately, conclusions can drift from the data. In 72 randomized trials whose main outcome showed no statistically significant difference, the abstract's conclusions presented the findings in a more favorable light ("spin") in 42, or 58% [9]. If you can, read the results section, not just the conclusion.

Where claims get distorted on the way to you

Claims often become stronger as they travel from the study to the headline. A study of 462 health-related press releases from 20 UK universities, compared with the underlying papers and 668 news stories, looked at three kinds of exaggeration: advice to change behavior, causal claims drawn from correlational research, and conclusions about humans drawn from animal research [10]. The authors concluded: "Exaggeration in news is strongly associated with exaggeration in press releases" [10]. A headline is not the study, and the press release is not either.

Supplement labels need a separate kind of reading. In the U.S., the FDA does not approve dietary supplements before they are marketed [11]. A supplement label may carry a "structure/function" claim about how an ingredient affects the body's structure or function. Such a claim must be accompanied by a disclaimer that the FDA has not evaluated it, and the company must have substantiation that it is truthful and not misleading [11]. So a label claim tells you what the company says. It does not tell you that a regulator has reviewed the evidence. The same six questions apply.

What these questions can and cannot tell you

These questions help you match your confidence to the evidence. They cannot turn uncertain evidence into a clear yes or no. Some useful practices have little research simply because no one has funded large trials. Some well-designed studies disagree with each other. And a finding in one group of people may not apply to you.

Weak evidence is not the same as a false claim. It means the claim is not yet established. "Promising but not yet established" is an honest and useful category, and many questions in nutrition and the microbiome currently sit there. The goal is calibration: holding a belief about as firmly as the evidence allows, and updating it as better studies arrive.

A practical rule: when a claim affects your health decisions, look for agreement across several human studies, ideally summarized in a systematic review, before treating it as settled. If a claim would lead you to stop or change a prescribed treatment, or to start a supplement while pregnant, taking medication, or managing a health condition, discuss it with a clinician or pharmacist first.

How HEXABIOME Learn applies this framework

We use these same questions when writing every article on HEXABIOME Learn. In practice, that means:

• We name the study type, population, number of participants, and outcome whenever we report a finding.
• We separate human, animal, and lab evidence, and we label biomarker results as biomarker results.
• Where a finding could be read as a health or treatment claim, we quote the researchers' own words and cite the paper.
• Each article states what the evidence does not show.
• Articles do not discuss our products.

HEXABIOME is a probiotic supplement company, which is exactly why you should apply these six questions to what we publish too. Our process and how we handle corrections are described in How we research and correct articles.

The bottom line

You do not need to read every study to judge a health claim; you need to know what kind of evidence sits behind it. Human randomized trials and well-reported systematic reviews carry the most weight, while single small studies, animal results, and biomarker changes are early signals. Associations, early findings, and press-release wording often overstate what research shows. The most useful next step is to ask the six questions the next time a claim catches your attention.